معرفی
Michele Emdin is a Full Professor of Cardiology at the Sant’Anna School of Advanced Studies and a Contract Professor of Pathophysiology at the University of Pisa. He serves as Chief of Cardiology and Director of the Cardiothoracic Department at the Foundation G. Monasterio Teaching Hospital in Tuscany. With dual MD and PhD degrees from Pisa and Milan Universities, his career spans over three decades in cardiovascular medicine, focusing on heart failure, cardiac amyloidosis, cardio-oncology, and neurohumoral mechanisms. He leads the Health Sciences Interdisciplinary Center at Sant’Anna and coordinates the PhD Program in Health Science, Technology, and Management.
His education includes a Medical Degree (1987), Cardiovascular Pathophysiology PhD (1992), and a Master’s in Health Service Management (2009). Research collaborations span international networks, addressing biomarkers, cardiomyopathy mechanisms, and nanotechnology applications. He has authored over 700 peer-reviewed articles, edited five books, and served on editorial boards of journals like the European Journal of Cardiovascular Prevention and the International Journal of Cardiology.
Emdin’s awards include the Great Officer of the Italian Republic (2022) and the Matteotti Prize for his historical medical text Vite Sospese. His research innovations include early cancer-cardiac damage detection and prevention of sudden cardiac death in youth. He mentors over 60 students annually and advocates for medical ethics and education.
- Key Roles: Department Chief, PhD Coordinator, Hospital Director
- Research Foci: Amyloidosis, Heart Failure, Cardio-Oncology, Biomarkers
- Awards: Italian Presidential Honors, Matteotti Prize, Health Ministry Award
- Academic Engagements: Ethics Committees, Medical Education Innovations, SIMULABO Lab Founder
His recent publications (2025) emphasize advanced diagnostic techniques for cardiac amyloidosis, arrhythmia risk prediction, and multidisciplinary management of cardiomyopathies. He bridges clinical practice with translational research, impacting both patient care and training next-generation clinicians.
